Cigna Group (NYSE:CI – Get Free Report) CEO David Cordani bought 4,134 shares of the business’s stock in a transaction dated Monday, November 3rd. The shares were purchased at an average price of $241.88 per share, for a total transaction of $999,931.92. Following the transaction, the chief executive officer directly owned 157,935 shares of the company’s stock, valued at approximately $38,201,317.80. This represents a 2.69% increase in their position. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink.
Cigna Group Stock Performance
Shares of CI stock opened at $259.50 on Thursday. The stock has a market capitalization of $69.32 billion, a PE ratio of 14.16, a price-to-earnings-growth ratio of 0.88 and a beta of 0.44. Cigna Group has a 52-week low of $239.51 and a 52-week high of $350.00. The stock’s 50-day moving average price is $294.83 and its 200 day moving average price is $304.52. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.65.
Cigna Group (NYSE:CI – Get Free Report) last issued its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.64 by $0.19. The firm had revenue of $69.57 billion for the quarter, compared to analysts’ expectations of $66.40 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The firm’s revenue for the quarter was up 9.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $7.51 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, equities research analysts forecast that Cigna Group will post 29.77 EPS for the current year.
Cigna Group Dividend Announcement
Wall Street Analysts Forecast Growth
Several equities analysts recently issued reports on CI shares. Truist Financial dropped their price target on Cigna Group from $375.00 to $310.00 in a research report on Friday, October 31st. Jefferies Financial Group restated a “buy” rating and issued a $310.00 price target on shares of Cigna Group in a research report on Monday. TD Cowen lowered their price objective on Cigna Group from $387.00 to $333.00 and set a “buy” rating on the stock in a report on Tuesday. Raymond James Financial reaffirmed a “strong-buy” rating on shares of Cigna Group in a report on Monday. Finally, Guggenheim lowered their price objective on Cigna Group from $350.00 to $309.00 in a report on Friday, October 31st. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $344.91.
View Our Latest Stock Report on CI
Institutional Investors Weigh In On Cigna Group
Several institutional investors have recently modified their holdings of the company. Financial Network Wealth Advisors LLC boosted its stake in shares of Cigna Group by 26.8% during the 1st quarter. Financial Network Wealth Advisors LLC now owns 161 shares of the health services provider’s stock worth $53,000 after acquiring an additional 34 shares in the last quarter. Pathway Financial Advisers LLC boosted its stake in shares of Cigna Group by 2.3% during the 2nd quarter. Pathway Financial Advisers LLC now owns 1,501 shares of the health services provider’s stock worth $496,000 after acquiring an additional 34 shares in the last quarter. Armstrong Advisory Group Inc. boosted its stake in shares of Cigna Group by 17.7% during the 3rd quarter. Armstrong Advisory Group Inc. now owns 226 shares of the health services provider’s stock worth $65,000 after acquiring an additional 34 shares in the last quarter. Central Pacific Bank Trust Division boosted its stake in shares of Cigna Group by 1.0% during the 2nd quarter. Central Pacific Bank Trust Division now owns 3,440 shares of the health services provider’s stock worth $1,137,000 after acquiring an additional 35 shares in the last quarter. Finally, HM Payson & Co. boosted its stake in shares of Cigna Group by 0.9% during the 3rd quarter. HM Payson & Co. now owns 3,785 shares of the health services provider’s stock worth $1,091,000 after acquiring an additional 35 shares in the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.
About Cigna Group
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
See Also
- Five stocks we like better than Cigna Group
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- 3 Cash-Rich Stocks With High Growth Potential Right Now
- Insider Trades May Not Tell You What You Think
- Why Vertical Aerospace Stock Could Double After This Flight Test
- Trading Halts Explained
- Amazon: Breakout Confirmed—Here’s Where It Could Go Next
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
